Bronchial thermoplasty: State of the art.

Respirology

Division of Pulmonary and Critical Care Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Published: September 2022

Since the publication of a sham-controlled, randomized trial (AIR2) and subsequent marketing approval by the US Food and Drug Administration, we have significantly advanced our understanding of bronchial thermoplasty (BT)'s scientific basis, long-term safety, clinical efficacy and cost-effectiveness. In particular, the last 2 years have witnessed multiple research publications on several of these counts. In this review, we critically appraise our evolving understanding of BT's biologic underpinnings and clinical impact, offer an evidence-based patient workflow guide for the busy pulmonologist and highlight both current challenges as well as potential solutions for the researcher and the clinician.

Download full-text PDF

Source
http://dx.doi.org/10.1111/resp.14312DOI Listing

Publication Analysis

Top Keywords

bronchial thermoplasty
8
thermoplasty state
4
state art
4
art publication
4
publication sham-controlled
4
sham-controlled randomized
4
randomized trial
4
trial air2
4
air2 subsequent
4
subsequent marketing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!